Moteur de recherche d’entreprises européennes

Financement de l’UE (8 857 813 €) : Découvrir les causes de trois cancers mal compris en Europe Hor 09/12/2022 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Découvrir les causes de trois cancers mal compris en Europe

"The overall goal of DISCERN is to understand the causes of three poorly understood cancers in Europe; renal, pancreatic and colorectal cancer, and help to explain their geographical distribution, including their high incidence in central and eastern Europe. This will be achieved by combining large-scale European biorepositories comprising population-based cohorts and tumour case-series with state-of-the-art molecular profiling techniques and machine learning approaches. In particular, DISCERN will identify potential new causal risk factors for the three cancers using novel exposomics and proteomics scans, as well detailed geospatial and environmental exposure information from 16 large-scale epidemiological cohorts including almost 900,000 individuals. It will also explore biological mechanisms on how these risk factors are potentially causing these cancer types with a focus on promoting factors in normal tissues using deep sequencing, single cell multi-omics and spatial proteomics. The causal effects of identified cancer risk factors and the cellular signalling responses they trigger will be further evaluated using a panel of stem cells and colon, renal and pancreatic 3D organoids. The results from DISCERN will be disseminated to citizens, patients and policy makers through collaborating patient and participant organizations. DISCERN will provide the critical evidence base required to develop new prevention strategies to tackle the growing burden of renal, pancreatic and colorectal cancer in Europe. This action is part of the Cancer Mission cluster of projects on ""Understanding""."


Imperial College of Science Technology and Medicine ?
Centre International de Recherche sur le Cancer 2 443 529 €
Digestive Cancers Europe Dice 87 500 €
Fundacio Institut D'Investigacio Biomedica de Bellvitge 0,00 €
Fundacio Institut de Recerca Biomedica (Irb Barcelona) 1 246 250 €
Institut Catala D'Oncologia 118 750 €
Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement 202 735 €
Instituto Neurologico Mediterraneo Neuromed S.p.A. 58 763 €
Instytut Medycyny Pracy Imienia prof. Dra Med. Jerzego Nofera w Lodzi 73 006 €
Kungliga Tekniska Hoegskolan 1 238 595 €
Masarykova Univerzita 772 744 €
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy 57 775 €
Pancreatic Cancer Europe 87 500 €
Stichting Ikcc 87 500 €
Tartu Ulikool 245 466 €
Universita Degli Studi Di Torino 173 946 €
Universiteit Leiden 1 175 425 €
Universiteit Utrecht 701 783 €
Universitetet I Tromsoe - Norges Arktiske Universitet 86 548 €

https://cordis.europa.eu/project/id/101096888

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Imperial College of Science Technology and Medicine, Londres, Royaume Uni.